HCmed Innovations Co (TPE:6934) Net Current Asset Value: NT$4.09 (As of Dec. 2025) — 79% Below Median


TPE:6934 HCmed Innovations Co Ltd TPE:6934
11 GF Score
Price NT$68.00
! 4 Warning Signs
View Full Analysis

What is HCmed Innovations Co Net Current Asset Value?

HCmed Innovations Co TPE:6934 -2.16% 11 Net Current Asset Value is NT$4.09 as of Dec. 2025, which is 100% below its 10-year median of 19.32. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 568 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 83.98% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

HCmed Innovations Co's net current asset value per share for the quarter that ended in Dec. 2025 was NT$4.09.

The historical rank and industry rank for HCmed Innovations Co's Net Current Asset Value or its related term are showing as below:

TPE:6934' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 16.63   Med: 19.32   Max: 21.74
Current: 16.63

During the past 5 years, the highest Price-to-Net-Current-Asset-Value Ratio of HCmed Innovations Co was 21.74. The lowest was 16.63. And the median was 19.32.

TPE:6934's Price-to-Net-Current-Asset-Value is ranked worse than
83.98% of 568 companies
in the Medical Devices & Instruments industry
Industry Median: 5.1 vs TPE:6934: 16.63

HCmed Innovations Co  (TPE:6934) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


HCmed Innovations Co Net Current Asset Value Related Terms


HCmed Innovations Co Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for HCmed Innovations Co's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCmed Innovations Co Net Current Asset Value Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Current Asset Value
-6.63 3.52 6.80 4.96 4.09

HCmed Innovations Co Quarterly Data
Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 4.96 6.49 5.09 4.09

TPE:6934 vs ABT, SYK, MDT: Net Current Asset Value Comparison

For the Medical Devices subindustry, HCmed Innovations Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's Price-to-Net-Current-Asset-Value falls into.


TPE:6934
11GF Score
HCmed Innovations Co Ltd TPE:6934
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCmed Innovations Co Net Current Asset Value Calculation

HCmed Innovations Co's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2025 is calculated as

Net Current Asset Value Per Share(A: Dec. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(287.555-153.755-0-0)/32.717
=4.09

HCmed Innovations Co's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2025 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(287.555-153.755-0-0)/32.717
=4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of NT$4.09 mean?
HCmed Innovations Co (TPE:6934) has a Net Current Asset Value of NT$4.09 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on HCmed Innovations Co and its competitors. This is 79% below median its historical median of 19.32. Over the past decade, HCmed Innovations Co's Net Current Asset Value has ranged from 16.63 to 21.74. According to the industry distribution chart, HCmed Innovations Co ranks #477 out of 568 companies in the Medical Devices & Instruments industry, placing it in the top 84%.
Is HCmed Innovations Co's Net Current Asset Value too high?
HCmed Innovations Co's current Net Current Asset Value of NT$4.09 is 79% below median its 10-year median of 19.32. Over the past 10 years, this metric has ranged from a low of 16.63 to a high of 21.74. Based on the distribution chart, HCmed Innovations Co ranks #477 out of 568 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #477 out of 568 companies for Net Current Asset Value. This places HCmed Innovations Co in the lower half of its industry. The industry median Net Current Asset Value is 5.10. Historically, HCmed Innovations Co's own Net Current Asset Value has ranged from 16.63 to 21.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.10, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current Net Current Asset Value is NT$4.09, which is 79% below median its own 10-year median of 19.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current Net Current Asset Value of NT$4.09. The current Net Current Asset Value is NT$4.09, which is 79% below median its 10-year median of 19.32. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current Net Current Asset Value is NT$4.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HCmed Innovations Co Business Description

Address Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score

Get the complete analysis for TPE:6934

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$68.00
Price